Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson's Disease Foundation Mobilizes Community to Address Unmet Needs of Women Living with Parkinson’s

The Parkinson's Disease Foundation® (PDF®) is pleased to launch its Women and PD Initiative, the first national coordinated effort dedicated to improving the health and well-being of women living with Parkinson’s disease. The initiative launches this week with a three-day conference in Florham Park, NJ.

“In this age of emerging gender-specific medicine, we can no longer assume that women, including those of us living with Parkinson’s disease, are simply small men with different reproductive systems. Women’s realities — biochemical, metabolic and societal — are different from men’s, and relate to research, medications, care and support,” said Robin Morgan, awardwinning author, feminist activist, and volunteer committee member for the Women and PD Initiative. “PDF’s Women and PD Initiative is an historic first step in energizing the community’s resolve to understand and address these realities, which will ultimately improve the lives of both women and men.”

According to a review conducted by PDF in 2013, there are significant unanswered questions and unmet needs for women with Parkinson’s disease. It revealed that women experience Parkinson’s disease differently, yet are underrepresented in clinical studies testing new treatments. It also found that women are less likely to see a specialist who can provide the best care — with one study estimating that it takes women 61 percent longer than men to see a specialist after disease onset. Additionally, 88 percent of women with Parkinson’s surveyed by PDF indicated that they want resources focused on women’s needs.

PDF’s Women and PD Initiative kicks off today with an interactive conference with sessions led by female health professionals from the fields of movement disorders, psychology, physical therapy, sexuality and wellness. The conference will foster community collaboration and more importantly, mobilize community leaders — 25 women living with PD who were selected through a nationally competitive application process — to take action in their own communities.

"Women living with Parkinson’s often have questions about their disease that are genderspecific, but have few places to turn. PDF’s Women and PD Initiative is working to create a space where women can share experiences, find answers and advocate for change. We are confident that through collaboration with our talented network of health professionals and women with Parkinson’s, we can put women’s needs on the map and galvanize the community to address them,” said Veronica Todaro, M.P.H., Vice President, National Programs at PDF.

The PDF Women and PD Initiative is led by volunteer committee members Susan Foster, Lori Katz, Robin Morgan and Karen Smith. 

Wednesday, September 16, 2015
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.